1. Home
  2. CRS vs ICLR Comparison

CRS vs ICLR Comparison

Compare CRS & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Carpenter Technology Corporation

CRS

Carpenter Technology Corporation

HOLD

Current Price

$338.24

Market Cap

15.4B

Sector

Industrials

ML Signal

HOLD

Logo ICON plc

ICLR

ICON plc

HOLD

Current Price

$202.62

Market Cap

15.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRS
ICLR
Founded
1910
1990
Country
United States
Ireland
Employees
N/A
N/A
Industry
Steel/Iron Ore
Biotechnology: Commercial Physical & Biological Resarch
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
15.4B
15.1B
IPO Year
N/A
1998

Fundamental Metrics

Financial Performance
Metric
CRS
ICLR
Price
$338.24
$202.62
Analyst Decision
Strong Buy
Buy
Analyst Count
5
14
Target Price
$374.60
$202.38
AVG Volume (30 Days)
983.1K
770.5K
Earning Date
01-29-2026
02-18-2026
Dividend Yield
0.24%
N/A
EPS Growth
82.03
N/A
EPS
8.18
7.47
Revenue
$2,893,200,000.00
$8,102,602,000.00
Revenue This Year
$7.30
N/A
Revenue Next Year
$8.97
$0.66
P/E Ratio
$41.05
$26.96
Revenue Growth
2.40
N/A
52 Week Low
$138.61
$125.10
52 Week High
$344.99
$228.29

Technical Indicators

Market Signals
Indicator
CRS
ICLR
Relative Strength Index (RSI) 59.89 71.89
Support Level $329.17 $180.48
Resistance Level $344.99 $184.93
Average True Range (ATR) 10.28 5.55
MACD 0.72 1.93
Stochastic Oscillator 77.76 96.68

Price Performance

Historical Comparison
CRS
ICLR

About CRS Carpenter Technology Corporation

Carpenter Technology Corp supplies specialty metals to a variety of end markets, including aerospace and defense, industrial machinery and consumer durables, medical, and energy, among others. The company's reportable segments include; Specialty Alloys Operations and Performance Engineered Products. It generates maximum revenue from the Specialty Alloys Operations segment. The SAO segment is comprised of the company's alloy and stainless steel manufacturing operations. This includes operations performed at mills predominantly in Reading and Latrobe, Pennsylvania, and surrounding areas as well as South Carolina and Alabama. Geographically, the company derives its maximum revenue from the United States and the rest from Europe, Asia Pacific, Mexico, Canada, and other regions.

About ICLR ICON plc

Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.

Share on Social Networks: